Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 4Terminated 3Active not recruiting 3Unknown 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Gynecologic 1

Conditions

Breast Neoplasms 12Colorectal Neoplasms 6Carcinoma, Non-Small-Cell Lung 6Prostatic Neoplasms 5Lung Neoplasms 4Triple Negative Breast Neoplasms 3Rectal Neoplasms 3Pancreatic Neoplasms 3Leukemia, Myeloid, Acute 3Leukemia, Megakaryoblastic, Acute 3Fallopian Tube Neoplasms 3Stomach Neoplasms 2Ovarian Neoplasms 2Obesity 2Neoplasms 2Leukemia, Myelomonocytic, Acute 2Leukemia, Monocytic, Acute 2Leukemia, Erythroblastic, Acute 2Leukemia, Eosinophilic, Acute 2Leukemia, Basophilic, Acute 2Hodgkin Disease 2Congenital Abnormalities 2Colonic Neoplasms 2Vulvar Neoplasms 1Urinary Bladder Neoplasms 1Thymus Neoplasms 1Thymoma 1Sezary Syndrome 1Sertoli-Leydig Cell Tumor 1Salivary Gland Neoplasms 1

Interventions

Taxes 1Paclitaxel 1Ifosfamide 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Has results × Carcinosarcoma × Clear all
NCT00954174 2021-09-30

Paclitaxel and Carboplatin or Ifosfamide in Treating Patients With Newly Diagnosed, Persistent or Recurrent Uterine, Ovarian, Fallopian Tube, or Peritoneal Cavity Cancer

GOG Foundation

Phase 3 Unknown
637 enrolled 18 charts
GynecologicSarcoma

Carcinosarcoma, Fallopian Tube Neoplasms, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡